1 min read
Add as a preferred source on GoogleKrystal Biotech Q3 Product Revenue Rises 30% to $127.3 Million
GAAP earnings per share were $2.05. Cash, cash equivalents and investments totaled $1.2 billion as of Sept. 30, 2026.
Krystal Biotech, Inc. posted $127.3 million in net product revenue for the third quarter, up from $97.8 million a year earlier, a 30.2% increase.
GAAP earnings per share were $2.05. Cash, cash equivalents and investments totaled $1.2 billion as of Sept. 30, 2026.
The results follow TokenPost’s earlier preview of the company’s Q3 estimates.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.